Insiders / Bredt David

Bredt David

CIK 2022087personinsider
Companies
1
First seen
Jan 5, 2026
Last activity
Feb 19, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Rapport Therapeutics, Inc. · RAPPExecutive393,075410,64210

All securities held

3 positions · latest reported per filing
CompanySecuritySharesAs of
Rapport Therapeutics, Inc.Common Stock393,075Feb 19, 2026
Rapport Therapeutics, Inc.Stock Option (Right to Buy)Derivative103,000Feb 2, 2026
Rapport Therapeutics, Inc.Stock Options (Right to Buy)Derivative88,080Feb 19, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Jan 15, 2026SellRAPP
Rapport Therapeutics, Inc.
Common Stock
$222.7K-8K
-2.05%
395,775
0.82% of shares
medium
Dec 31, 2025SellRAPP
Rapport Therapeutics, Inc.
Common Stock
$197.3K-7K
-1.60%
404,075
0.84% of shares
medium
Feb 17, 2026SellRAPP
Rapport Therapeutics, Inc.
Common Stock
$156.3K-5K
-1.37%
389,275
0.81% of shares
medium
Feb 17, 2026SellRAPP
Rapport Therapeutics, Inc.
Common Stock
$65.1K-2K
-0.57%
387,075
0.81% of shares
low
Feb 17, 2026SellRAPP
Rapport Therapeutics, Inc.
Common Stock
$25.2K-900
-0.23%
394,675
0.82% of shares
low
Feb 19, 2026ExerciseRAPP
Rapport Therapeutics, Inc.
Common Stock
$10.8K+6K
+1.55%
393,075
0.82% of shares
low
Jan 15, 2026SellRAPP
Rapport Therapeutics, Inc.
Common Stock
$5.5K-200
-0.05%
395,575
0.82% of shares
low
Feb 19, 2026ExerciseRAPP
Rapport Therapeutics, Inc.
Stock Options (Right to Buy)
-6K
-6.38%
88,080
0.18% of shares
low
Feb 2, 2026GrantRAPP
Rapport Therapeutics, Inc.
Stock Option (Right to Buy)
+103K
103,000
0.21% of shares
low
Dec 31, 2025GrantRAPP
Rapport Therapeutics, Inc.
Common Stock
-18K
-4.20%
410,642
0.86% of shares
low